Prostate Cancer Expert Panel Positive on Medivation's (MDVN) Xtandi, UBS Says; Shares Worth Up to $75 in Takeout

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. ONON
6. AAPL
7. TRMD
8. AZN
9. BETR
10. DIS

Go back to Prostate Cancer Expert Panel Positive on Medivation's (MDVN) Xtandi, UBS Says; Shares Worth Up to $75 in Takeout

Medivation (MDVN) Worth $51-$75 in Takeover - Jefferies

March 31, 2016 11:40 AM EDT

Looking through the rumors, Jefferies analyst, Biren Amin, values shares of Medivation (NASDAQ: MDVN) in baseline and synergistic scenarios. However, he made no change to his Hold rating or $39 PT.

The baseline scenario values MDVN at $39/share thru a DCF, and included $200M of annual synergies from OpEx. The analyst assumed the acquirers tax rate and calculated a potential... More

Medivation (MDVN) Crosses Above 200 DMA Amid Takeover Speculation

March 31, 2016 10:12 AM EDT

Medivation (NASDAQ: MDVN), up early on takeover speculation, just crossed above its 200 Day Moving Average.

Shares are up 17.4% early to $43.89

... More

Pre-Open Stock Movers 03/31: (GNCA) (MDVN) (MNOV) Higher; (EGLE) (PRGS) (MOV) Lower (more...)

March 31, 2016 9:31 AM EDT

Eagle Bulk Shipping, Inc. (Nasdaq: EGLE) 40% LOWER; announced that it has reached an agreement with the Company's lenders and holders of approximately 75% of the Company's outstanding equity for a comprehensive balance-sheet recapitalization. The transaction provides Eagle Bulk with approximately $105 million in incremental liquidity,... More

Medivation (MDVN) Could Be Worth Up to $75/Share in a Takeover - Credit Suisse

March 31, 2016 6:24 AM EDT

Credit Suisse analyst Kennen MacKay bumped his price target on Medivation (NASDAQ: MDVN) to $49.00 (from $48.00) following reports the company hired bankers to fend off a takeover. The firm maintained an Outperform rating.

The analyst notes Medivation has become vulnerable to a takeover given the... More